Home
About
FAQ
History (14)
Prajmaline
Activation of epidermal growth factor receptor is required for Chlamydia trachomatis development.
Parallel single nucleotide polymorphism genotyping by surface invasive cleavage with universal detection.
Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Dapsone as corticosteroid-sparing therapy for Sweet syndrome.
See All 14 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dapsone as corticosteroid-sparing therapy for Sweet syndrome.
Hrin ML, Feldman SR, Huang WW. Dapsone as corticosteroid-sparing therapy for Sweet syndrome. J Am Acad Dermatol. 2021 Mar 02.
View in:
PubMed
authors with profiles
Steven R. Feldman MD, PhD
Dalane W. Kitzman MD